Back to Rankings

CPRX

CatalystA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
CPRX vs peer average
77/100
CPRX vs. peer average (A vs. C)
Grade spread
B 3 · C 6
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

ACAD is the first available peer comparator.

ACADIA is a better commercial specialty-pharma comp for revenue quality and margin discipline, but it is not as directly comparable on merger-arbitrage pricing.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerACADACADIA
CPRX
Catalyst
ACAD
ACADIA
Grade
A
C
Momentum
87
27
Value
67
62
Sentiment
46
75
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs ACAD

CPRX / ACAD
Grade Position
Above peers
CPRX vs. peer average (A vs. C)
77/100
Momentum
87
CPRX
Value
67
CPRX
Sentiment
46
ACAD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CPRX
1
ACAD
ACAD
C
60/100
+2
2
GILD
GILD
C
60/100
+2
3
KNSA
KNSA
C
60/100
+2
4
VCYT
Veracyte Inc Common
B
80/100
+1
5
TXG
10x Genomics Inc Class A Common
C
60/100
+2
ACAD is the first peer returned for this comparison set.